bromodeoxyuridine has been researched along with Cardiomyopathy, Hypertrophic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcalai, R; Eminaga, S; Gorham, JM; Hoffman, SR; Kim, JB; Konno, T; Markwald, RR; Molkentin, JD; Nayor, M; Norris, RA; Schmitt, JP; Seidman, CE; Seidman, JG; Tager, AM; Teekakirikul, P; Toka, O; Wakimoto, H; Wang, L; Wolf, CM | 1 |
| Arino, T; Nagai, M; Nagano, M; Ohkubo, T; Tsuchiya, M | 1 |
2 other study(ies) available for bromodeoxyuridine and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.
Topics: Animals; Bromodeoxyuridine; Cardiomyopathy, Hypertrophic; Cell Proliferation; Disease Models, Animal; Fibrosis; Losartan; Mice; Mutation; Myocardium; Myocytes, Cardiac; Sarcomeres; Signal Transduction; Transforming Growth Factor beta | 2010 |
Growth factor for cardiac hypertrophy.
Topics: Animals; Bromodeoxyuridine; Cardiomyopathy, Hypertrophic; Cell Division; Cells, Cultured; Chick Embryo; Disease Models, Animal; G2 Phase; Growth Substances; Heart; Male; Myocardium; Rats; Rats, Wistar; S Phase; Tissue Extracts | 1993 |